Van T. Hoang - Concepedia

Author

Van T. Hoang

Also Known As

Boehling, Julia R., Hoang, Van Tuyet, V Hoang, V T Hoang, VT Hoang, Van Hoang, Van MT. Hoang, Van T. Hoang, Vu Trung Kien Hoang, Văn Tuân Hoàng

Publications

527

Citations

H-Index

Concepts

All Affiliations

Tulane University Duquesne University Indiana University Bloomington Tulane Medical Center Louisiana State University Health Sciences Center New Orleans

About

Van T. Hoang is an author at Tulane University specializing in medicine, breast cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	199
2	Engineering	1	1	15
3	Health Sciences	1	1	23
4	Natural Sciences	1	1	13
5	Biochemistry	1	1	13

Van T. Hoang

Publications

388

Citations

H-Index

Page 1

	Year	Citations
Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators Lyndsay V. Rhodes, Chandra R. Tate, H. Chris Segar, Breast Cancer Research and Treatment Breast OncologyEmt Master RegulatorsZeb FamilyPan-dac Inhibitor PanobinostatMedicine	2014	101
MicroRNA‐335‐5p and ‐3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance Elizabeth C. Martin, Adrienne K. Conger, Thomas J. Yan, FEBS Letters	2016	47
Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1 Lyndsay V. Rhodes, Chandra R. Tate, Van T. Hoang, Oncogenesis Liver Kinase B1OncologyBreast OncologyCell RegulationMedicine	2015	35
The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells Van T. Hoang, Katherine M. Nyswaner, Pedro Torres‐Ayuso, Journal of Biological Chemistry	2020	29
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model Margarite D. Matossian, Hope E. Burks, Steven Elliott, BMC Cancer	2019	25
A novel patient-derived xenograft model for claudin-low triple-negative breast cancer Margarite D. Matossian, Hope E. Burks, Annie C. Bowles, Breast Cancer Research and Treatment Breast OncologyMedicineCancer GrowthBreast CancerOncology	2018	23
Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model Margarite D. Matossian, Hope E. Burks, Steven Elliott, Oncoscience	2018	22
ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer Van T. Hoang, Margarite D. Matossian, Deniz A. Uçar, Frontiers in Oncology	2020	20
Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer Akshita B. Bhatt, Mohit Gupta, Van T. Hoang, Frontiers in Oncology	2019	17
The role of MEK1/2 and MEK5 in melatonin‐mediated actions on osteoblastogenesis, osteoclastogenesis, bone microarchitecture, biomechanics, and bone formation Fahima Munmun, Omair A. Mohiuddin, Van T. Hoang, Journal of Pineal Research	2022	16

Page 1